Pregnancy in women with valvular heart disease

Heart

Volumn 93, Issue 5, 2007, Pages 552-558

  Stout, Karen K ^a,b   Otto, Catherine M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDRALAZINE; LOW MOLECULAR WEIGHT HEPARIN; NITROPRUSSIDE SODIUM; WARFARIN;

AORTA STENOSIS; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PATIENT CARE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; REVIEW; RISK FACTOR; VALVULAR HEART DISEASE; ECHOGRAPHY; FEMALE; METHODOLOGY; PREGNANCY COMPLICATION; PRENATAL CARE;

FEMALE; HEART VALVE DISEASES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; ULTRASONOGRAPHY, PRENATAL;

EID: 34247846189     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.067975     Document Type: Review

References (31)

1. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21.
2. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-84.
3. Soler-Soler J, Galve E. Worldwide perspective of valve disease. Heart 2000;83:721-5.
4. Dore A, Somerville J. Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 1997;18:1659-62.
5. Reimold SC, Rutherford JD. Clinical practice. Valvular heart disease in pregnancy. N Engl J Med 2003;349:52-9.
6. Thorne SA. Pregnancy in heart disease. Heart 2004;90:450-6.
7. van Oppen AC, Stigter RH, Bruinse HW. Cardiac output in normal pregnancy: a criticai review. Obstet Gynecol 1996;87:310-18.
8. Easterling TR, Carlson KL, Schmucker BC, et al. Measurement of cardiac output in pregnancy by Doppler technique. Am J Perinatol 1990;7:220-2.
9. Robson SC, Hunter S, Moore M, et al. Haemodynamic changes during the Puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol 1987;94:1028-39.
10. Easterling TR, Benedetti TJ, Schmucker BC, et al. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study [see comments]. Obstet Gynecol 1990;76:1061-9.
11. Robson SC, Dunlop W, Boys RJ, et al. Cardiac output during labour. BMJ (Clin Res Ed) 1987;295:1169-72.
12. Bonow RO, Carabello BA, deLeon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on management of patients with valvular heart disease). J Am Coll Cardiol 1998;32:1486-588.
13. Qasqas SA, McPherson C, Frishman WH, et al. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev 2004;12:201-21.
14. Qasqas SA, McPherson C, Frishman WH, et al. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev 2004;12:240-61.
15. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-801.
16. Patel JJ, Mitha AS, Hassen F, et al. Percutaneous balloon mitral valvotomy in pregnant patients with tight pliable mitral stenosis. Am Heart J 1993;125:1106-9.
17. Ribeiro PA, Fawzy ME, Awad M, et al. Balloon valvotomy for pregnant patients with severe pliable mitral stenosis using the Inoue technique with total abdominal and pelvic shielding. Am Heart J 1992;124:1558-62.
18. Weiss BM, von Segesser LK, Alon E, et al. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996. Am J Obstet Gynecol 1998;179:1643-53.
19. Sullivan HJ. Valvular heart surgery during pregnancy. Surg Clin North Am 1995;75:59-75.
20. Myerson SG, Mitchell AR, Ormerod OJ, et al. What is the role of balloon dilatation for severe aortic stenosis during pregnancy? J Heart Valve Dis 2005;14:147-50.
21. Veldtman GR, Connolly HM, Grogan M, et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004;44:174-80.
22. Meijer JM, Pieper PG, Drenthen W, et al. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 2005;91:801-5.
23. Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol 2005;46:291-8.
24. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy. Circulation 2003;107:1240-6.
25. Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41.
26. Salem DN, Stein PD, Al Ahmad A, et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004;126:457S-82S.
27. Elkayam U, Singh H, Irani A, et al. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004;9:107-15.
28. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995;16:1320-30.
29. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191-6.
30. Ginsberg JS, Chan WS, Bates SM, et al. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003;163:694-8.
31. Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol 2005;46:223-30.